Chemed Corp (NYSE:CHE)
$ 571.18 -4.06 (-0.71%) Market Cap: 8.62 Bil Enterprise Value: 8.51 Bil PE Ratio: 30.74 PB Ratio: 7.28 GF Score: 96/100

Chemed Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 14, 2019 / 10:00PM GMT
Release Date Price: $329.33 (-0.77%)
Joanna Sylvia Gajuk;Kevin J. McNamara
BofA Merrill Lynch, Research Division - VP;Chemed Corporation - CEO, President &amp

Thank you so much for hanging out with us here. My name is Joanna Gajuk. I cover some of the post-acute care names at Bank of America. And itâs my pleasure now to host this conversation with Chemed. One of the largest hospice operators, but also compete in also plumbing and water restoration business.

And today, with us, we have Kevin McNamara, President and CEO; and also David Williams, CFO and they were -- they preferred a Q&A session, which is also the preferred form for us. So, I guess I'll start. This is healthcare conference, right. So obviously, everyone will to talk about hospice primarily and obviously the most recent topic is the rebasing, that's proposed by CMS for fiscal 2020. By our estimate, we come up with like a 3% increase for VITAS rates based on the mix. Obviously that's before the market basket. So can you comment of how you -- what's your estimate for the -- for this rebasing for VITAS based on -- have you read the reg?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot